BIOSENSIA
Desconocido
ADVANTAGE: ADvanced Validation of A Novel TB Active disease diagnostic to address Global unmet needs a Europea...
BIOSENSIA LIMITED
participó en un
H2020:
H2020-SMEInst-2014-2015
Tuberculosis (TB) remains an EU and global healthcare priority resulting in over 1.4 million deaths each year. Despite this and efforts to r...
2015-06-18 - 2019-03-31 | Financiado
2015-06-18 - 2019-03-31 | Financiado
LabOnFoil: Laboratory Skin Patches and SmartCards based on foils and compatible with a smartphone
BIOSENSIA LIMITED
participó en un
FP7:
Conventional analytical methods often require a large sample volume and complicated time-consuming protocols. The objective of this project...
Financiado
Financiado
PORTFASTFLU: Portable automated test for fast detection and surveillance of influenza
BIOSENSIA LIMITED
participó en un
FP7:
The PORTFASTFLU’s objective is to develop and validate a rapid diagnostic test for influenza that will be used as point-of-care systems in d...
Financiado
Financiado
* No se disponen de datos de la empresa actual.